Skip to main content
THERAGEN ETEX CO.,LTD. logo

THERAGEN ETEX CO.,LTD. — Investor Relations & Filings

Ticker · 066700 ISIN · KR7066700006 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2025-03-24 Capital/Financing Update
Country KR South Korea
Listing KO 066700

About THERAGEN ETEX CO.,LTD.

http://www.theragenetex.com/

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Korean financial authorities. It details the amendment of a previously filed capital increase plan, specifically changing the listing date of new shares. This falls under the category of capital structure changes and financing updates, which is classified as 'CAP'.
2025-03-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership (crossing thresholds or changes in purpose of holding). This falls under the 'Major Shareholding Notification' category.
2025-03-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by major shareholders (Ko Jae-hoon and others) in the company 'Theragen Etex' (066700). This type of filing is specifically used to notify the market when a person or entity crosses a significant ownership threshold (typically 5% or more) or changes their holdings significantly. In the provided classification schema, this falls under 'Major Shareholding Notification'.
2025-03-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider shareholding changes, which falls under the 'Director's Dealing' category (DIRS) as it details the acquisition of shares by an individual identified as a major shareholder/executive.
2025-03-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory requirement for insiders (directors/major shareholders) to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category in the provided taxonomy.
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '테라젠이텍스'. It provides a summary of audit opinions, key financial data (assets, liabilities, equity, profit/loss), and auditor information. While it contains audit-related data, it is a standard regulatory disclosure form used in the Korean market (DART/KRX) to announce the receipt and submission of the audit report to the public, rather than the full, multi-page audit report document itself. Given the structure and the nature of the disclosure, it fits the 'Audit Report / Information' category as it provides the core audit results and financial summary. FY 2024
2025-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.